跳至主要内容
临床试验/JPRN-UMIN000007234
JPRN-UMIN000007234已完成未知

The study of finding appropriate usage/dosage of peramivir on hemodialysis patient, an open-label study. - The study of finding appropriate usage/dosage of peramivir on hemodialysis patient, an open-label study.

Tokyo Women's Medical University Hospital0 个研究点目标入组 6 人开始时间: 2012年2月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) History of hypersensitivity, allergy or serious adverse drug event caused by oseltamivir phosphate, zanamivir hydrate, peramivir hydrate or raninanivir. 2)Patient with contraindications of 1) drugs. 3)Hepatic disorder. 4) Women who are pregnant or suspected to be pregnant and women who are breast-feeding. 5) Any other patients whose condition is inappropriate for the evaluation of this clinical study as judged by the investigator.

研究者

发起方
Tokyo Women's Medical University Hospital

相似试验